Abstract

Previous studies suggest that granulocyte colony-stimulating factor (G-CSF) can promote bone marrow derived progenitor cells to mediate cardiovascular repair, potentially reversing mechanical dysfunction in chronic ischaemic heart disease and post myocardial infarction. Two models were used in the present study both using a surgical ameroid constrictor to induce arterial stenosis. The first model used the carotid artery of rabbits. They were divided into high fat diet (inducing atherosclerosis) or normal fat diet (control) groups. Each was subdivided into surgical exposure group without constrictor, ameroid constrictor receiving normal saline or receiving G-CSF 15 µg/kg/day. Endothelial markers of endothelial nitric oxide synthase and endothelin 1 were increased by the use of ameroid constrictor in both atherosclerotic and non-atherosclerotic mice, however were not further altered by G-CSF. Scanning electron microscopy indicated that ameroid constrictor application altered endothelial morphology from an oval shape to a round shape and this was more prominent in the atherosclerotic compared with the non-atherosclerotic group. G-CSF injection increased the number of endothelial cells in all groups. The second model used the left coronary artery of pigs. They were equally divided into following groups, receiving normal saline (control), G-CSF 2.5 µg/kg/day (low dose), 5 µg/kg/day (medium dose) and 10 µg/kg/day (high dose) for 5 days. G-CSF at a low or high dose worsened intimal hyperplasia however at a medium dose improved it. In conclusion, G-CSF had no effect in a rabbit carotid artery model of atherosclerosis. Its effects on the porcine heart were dose-dependent; arterial disease worsened at a low or high dose, but improved at a medium dose.

Highlights

  • Stem cell‐based therapy has been demonstrated as a good option for cardiac repair following myocardial infarction (MI)

  • In the FIRSTLINE‐AMI study, subcutaneous injection of granulocyte colony‐stimulating factor (G‐CSF) shortly after successful primary percutaneous coronary intervention (PCI) in patients suffering from acute ST elevation MI was demonstrated to mobilize mononuclear blood stem cells [3]

  • The present study aimed to investigate the effects of G‐CSF in a novel rabbit model of chronic obliterative arterial disease, which was generated by clamping the carotid artery using a surgical ameroid constrictor

Read more

Summary

Introduction

Stem cell‐based therapy has been demonstrated as a good option for cardiac repair following myocardial infarction (MI). Previous clinical trials have demonstrated efficacy using a traumatic method of bone marrow aspiration, culture of the bone marrow stem cells and intracoronary infusion of this end‐product [1] Another less invasive option is to use granulocyte colony‐stimulating factor (G‐CSF) to mobilize bone marrow‐derived progenitor cells to undertake tissue repair [2]. In the FIRSTLINE‐AMI study, subcutaneous injection of G‐CSF shortly after successful primary percutaneous coronary intervention (PCI) in patients suffering from acute ST elevation MI was demonstrated to mobilize mononuclear blood stem cells [3]. This resulted in enhanced resting wall thickening of the infarcted myocardium, improvement of wall motions and systolic function without apparent re‐stenosis. Usage of G‐CSF in acute MI may be a double‐edged sword, due to the fact that it may paradoxically reduce the migratory capacity of bone marrow‐derived progenitor cells into the ischaemic myocardium and there is a need to optimize the cytokine profile with other agents to ensure their successful migration [7]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.